CEACAM5 and lung adenocarcinoma: This study presents a retrospective analysis of clinical features associated with STAS in stage I lung adenocarcinoma, utilizing seven risk factors (CEA, vascular convergence, proGRP, age, AFP, smoking history, and CTR) to develop predictive models.